Mazur Leonard L
SEC insider (Form 3/4/5 filer). CIK 0001463414. Chief Executive Officer at CITIUS ONCOLOGY, INC. (CTOR) and 1 other issuer. 11 reported Form 4/5 transactions since Sep 2024; latest on Sep 19, 2025. Located in CRANFORD, NJ.
Companies Mazur Leonard L has filed insider reports for
- CITIUS ONCOLOGY, INC. (CTOR): Director, Officer, Chief Executive Officer
- Citius Pharmaceuticals, Inc. (CTXR): Director, Officer, 10% Owner, Chief Executive Officer
Mazur Leonard L
CIK: 0001463414
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Sep 19, 2025CTOR
CITIUS ONCOLOGY, INC.
AwardDirect1.7M shares- - Aug 8, 2025CTXR
Citius Pharmaceuticals, Inc.
AwardDirectWarrant to Purchase Common Stock
89.4K shares- - Aug 8, 2025CTXR
Citius Pharmaceuticals, Inc.
DispositionDirectWarrant to Purchase Common Stock
125.5K shares- - Aug 8, 2025CTXR
Citius Pharmaceuticals, Inc.
AwardDirectWarrant to Purchase Common Stock
125.5K shares- - Aug 8, 2025CTXR
Citius Pharmaceuticals, Inc.
DispositionDirectWarrant to Purchase Common Stock
89.4K shares- - Dec 12, 2024CTOR
CITIUS ONCOLOGY, INC.
AwardDirectStock Option (Right to Buy)
800K shares- - Nov 7, 2024CTXR
Citius Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Purchase Common Stock)
600K shares- - Sep 25, 2024CTXR
Citius Pharmaceuticals, Inc.
DispositionDirectWarrant to Purchase Common Stock
2.2M shares- - Sep 25, 2024CTXR
Citius Pharmaceuticals, Inc.
AwardDirectWarrant to Purchase Common Stock
2.2M shares- - Aug 14, 2024CTXR
Citius Pharmaceuticals, Inc.
DispositionDirectWarrant to Purchase Common Stock
3.1M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 19, 2025 |  CTOR CITIUS ONCOLOGY, INC. | Award | 1,700,000 | - | - | Direct |
| Aug 8, 2025 |  CTXR Citius Pharmaceuticals, Inc. | Award Warrant to Purchase Common Stock | 89,388 | - | - | Direct |
| Aug 8, 2025 | CTXR Citius Pharmaceuticals, Inc. | Disposition Warrant to Purchase Common Stock | 125,490 | - | - | Direct |
| Aug 8, 2025 | CTXR Citius Pharmaceuticals, Inc. | Award Warrant to Purchase Common Stock | 125,490 | - | - | Direct |
| Aug 8, 2025 | CTXR Citius Pharmaceuticals, Inc. | Disposition Warrant to Purchase Common Stock | 89,388 | - | - | Direct |
| Dec 12, 2024 | CTOR CITIUS ONCOLOGY, INC. | Award Stock Option (Right to Buy) | 800,000 | - | - | Direct |
| Nov 7, 2024 | CTXR Citius Pharmaceuticals, Inc. | Award Stock Option (Right to Purchase Common Stock) | 600,000 | - | - | Direct |
| Sep 25, 2024 | CTXR Citius Pharmaceuticals, Inc. | Disposition Warrant to Purchase Common Stock | 2,234,700 | - | - | Direct |
| Sep 25, 2024 | CTXR Citius Pharmaceuticals, Inc. | Award Warrant to Purchase Common Stock | 2,234,700 | - | - | Direct |
| Aug 14, 2024 | CTXR Citius Pharmaceuticals, Inc. | Disposition Warrant to Purchase Common Stock | 3,137,255 | - | - | Direct |
1-10 of 11 transactions